I care. Understanding what happened is the key to avoiding it in future trials. And what holder doesn't care about that?
plus, have you considered an unlikely event - the US carrier results weren't botched but in fact a variation in manufacture has given us something unexpected and extremely effective against acne? Highly improbable I'll admit, but I haven't yet read any definitive or plausible reason for the variation. We need to know, and that's another reason why we should care?
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-70
-
- There are more pages in this discussion • 581 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 35.0¢ | $4.519M | 12.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 75362 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 326113 | 17 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |